Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease.

Morgan GR. and Carlyle BC., (2024), Sci Rep, 14

Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.

Yang H-S. et al, (2024), Brain

Cerebrospinal fluid biomarker profiling of diverse pathophysiological domains in Alzheimer's disease

Trombetta BA. et al, (2024), Alzheimer's and Dementia: Translational Research and Clinical Interventions, 10

Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer's disease in a large clinical sample.

de Geus MB. et al, (2023), Sci Rep, 13

Correction to "Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer's Disease".

Quinn JP. et al, (2023), J Am Soc Mass Spectrom

Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer's Disease.

Quinn JP. et al, (2023), J Am Soc Mass Spectrom

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment.

Kivisäkk P. et al, (2023), Front Neurol, 14

Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF.

Audrain M. et al, (2023), Brain Commun, 5

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease

Kivisäkk P. et al, (2022), Alzheimer's Research and Therapy, 14

Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease

Carlyle BC. et al, (2022), Frontiers in Neurology, 13

Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults

Yang HS. et al, (2022), Alzheimer's and Dementia, 18, 645 - 653

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment.

Kivisäkk P. et al, (2022), Brain Commun, 4

Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation.

Kandigian SE. et al, (2022), Brain Commun, 4

Characterization of novel neuropeptide proteolytic processing involved in dementia pathophysiology

Ethier EC. et al, (2021), Alzheimer's & dementia : the journal of the Alzheimer's Association, 17

Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study

Vasunilashorn SM. et al, (2021), Journal of Neuroinflammation, 18

Roadblock: improved annotations do not necessarily translate into new functional insights.

Hall NAL. et al, (2021), Genome Biol, 22

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases

Quinn JP. et al, (2021), Brain Communications

Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics

Carlyle BC. et al, (2021), Neurobiology of Aging, 105, 99 - 114

Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.

Trombetta BA. et al, (2021), BMC Infect Dis, 21

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.

Trombetta BA. et al, (2021), BMC Infect Dis, 21

Load More

Include forthcoming?